Vivek A. Kumar

He has co-authored over 30 peer-reviewed journal articles, over 4 dozen abstracts, co-invented over a dozen patents/applications; and is the director of the KumarLab for Biomaterials Drug Discovery, Delivery and Development. As of January 2020 Vivek has been cited over 1,100 times and has an H-index of 19.

NangioTx, his Biotechnology startup, was awarded the TMCx Bioventures 2015 1st place award, 2016 OPEN prize and was the winner of the first pitch competition at the first Life Pitch Science Competition by Mid Atlantic Bio Angels in 2016.. NangioTX was also a finalist for Mass Challenge 2016-2017 under the healthcare and life sciences category.

Vivek began his post-doctoral work in 2011 with Elliot Chaikof at the Wyss Institute for Biologically Inspired Engineering and Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. He continued his post-doctoral work with Jeffrey Hartgerink at Rice University in 2012 till 2016, and was awarded the NIH F32 fellowship for his work.

He received a BSc in biomedical engineering from Northwestern University in 2006. During his undergraduate program in biomedical engineering at Northwestern University, he did research in synthetic biomaterials in the lab of Guillermo Ameer, ScD. In 2006, he started pursuing his doctoral in bioengineering with Elliot Chaikof, MD, Ph.D, at Georgia Tech and Emory University in Atlanta, where he was awarded the American Heart Association Predoctoral Fellowship, graduating in 2011.

Vivek A. Kumar (born August 8, 1984) is an American scientist, innovator and entrepreneur. He is faculty at the New Jersey Institute of Technology (NJIT) and the Rutgers School of Dental Medicine; he is also the Dhiraj Shah Faculty Fellow at the NJIT Albert Dorman Honors College. At NJIT, he is the director of the KumarLab for Biomaterial Drug Discovery, Delivery, and Development Lab.